Emily Ramshaw: On Launching a Nonprofit Amid Covid-19

Emily Ramshaw: On Launching a Nonprofit Amid ...

Up next

Introducing ‘As We Work’

“As We Work” is a new podcast from the Wall Street Journal about the changing workplace and what you need to know to navigate it. Every week, we’ll speak with experts, Journal reporters, and you about how our jobs intersect with everything else. In season one, we break down how o ...  Show more

Toni Ko: On the Beauty Of Building Your Own Business

Toni Ko, founder of NYX Cosmetics and Bespoke Beauty Brands, tells WSJ's Veronica Dagher how she's launching a new makeup line amid the pandemic. Help us shape our future coverage of women and money. Share your feedback at wsj.com/secrets 

Recommended Episodes

When Women Compete
Women at Work

We discuss how women think about and approach competition at work and get advice on how to keep our disagreements — and people’s perceptions of them — from turning negative. Guest: Leah Sheppard. Our theme music is Matt Hill’s “City In Motion,” provided by Audio Network. 

Charity Dean on the Lessons of Covid-19 (Podcast)
Masters in Business

Bloomberg Opinion columnist Barry Ritholtz speaks with public-health expert Dr. Charity Dean, who as a health official in California was among the first Americans to recognize the grave threat posed by Covid-19. Her story is recounted in Michael Lewis's latest book, "The Premonit ...  Show more

#34: How I Became Brave Enough: My First Steps as an Entrepreneur feat. Sasha Shillcutt, MD, MS
The Passive Income MD Podcast

Dr. Sasha Shillcutt is the CEO & Founder of Brave Enough, a company that empowers and teaches professional women to lead. She is a well published researcher in cardiac anesthesiology and gender equity, author, and international speaker.

In 2016, she was awarded the nati ...

  Show more

Mylan's Heather Bresch: Big Pharma's First Woman CEO
Boss Files with Poppy Harlow

Mylan CEO Heather Bresch became the first woman to run a major pharmaceutical company in 2012. She opens about her experience being the only woman at the table, how the company's EpiPen controversy was a "defining moment" and made her a stronger leader, the state of health care i ...  Show more